Is a complete EOLS research report available?

No complete published report is available for Evolus, Inc. (EOLS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Evolus, Inc. (EOLS)

NASDAQ: EOLS · USD

$5.98

-0.01 (-0.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first EOLS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	393.8M
Revenue (ttm)	301.8M
Net income (ttm)	-43.4M
EPS (ttm)	-$0.67
Shares out	65.9M
Volume	697,012
Beta	1.32
Price target	$14.7	+145.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 301.8M
Net income (ttm): -43.4M
EPS (ttm): -$0.67
Market cap: 393.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All EOLS indicators

Market & fundamental data

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001570562
Company name	Evolus, Inc.
Country	United States
Country code	US
Cusip	30052C107
Employees	350
Employees Change	16%
Employees Change Percent	4.79
Enterprise value	$508.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	126.3
Industry PE Fwd	14.14
IPO Date	2018-02-08
Isin	US30052C1071
Last refreshed	2026-07-25
Market cap	$393.8M
Market cap category	Small-Cap
Price	$5.98
Price currency	USD
Rev Per Employee	862,260x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2834
Symbol	EOLS
Website	https://www.evolus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.03%
EV Sales Forward	1.49x
EV/Sales	1.69x
FCF yield	-10.19%
P/S ratio	1.3x
PS Forward	1.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-8.06%
EBITDA Margin	-5.32%
Gross margin	66.06%
Gross Profit	$199.3M
Gross Profit Growth	5.78%
Gross Profit Growth Q	4.81%
Gross Profit Growth3 Y	25.19%
Gross Profit Growth5 Y	38.37%
Net Income	$-43.4M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Pretax Margin	-14.1%
Profit Margin	-14.39%
Profit Per Employee	$-124,066
ROA	-9.06
Roa5y	-12.84
ROCE	-15.95
ROIC	-15.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-37.6%
Cagr3y	-6.9%
Cagr5y	-11.32%
EPS Growth Quarters	1
EPS Growth Years	3
Revenue Growth	9.56x
Revenue Growth Q	6.74x
Revenue Growth Quarters	24x
Revenue Growth Years	6x
Revenue Growth3 Y	24.49x
Revenue Growth5 Y	38.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.39
Assets	$220.6M
Cash	$49.8M
Current Assets	$138.9M
Current Liabilities	$68M
Debt	$164.9M
Equity	$-28.8M
Interest Coverage	-1.26
Liabilities	$249.4M
Long Term Assets	$81.7M
Long Term Liabilities	$181.4M
Net Cash	$-115.1M
Net Cash By Market Cap	$-29.23
Tangible Book Value	$-96.7M
Tangible Book Value Per Share	$-1.47
WACC	10.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.04
Inventory Turnover	5.88
Net Working Capital	$23.7M
Quick ratio	1.5
Working Capital	$70.9M
Working Capital Turnover	$4.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.53%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-37.58%
200-day SMA	5.89
3Y total return	-19.3%
50-day SMA	6.51
50-day SMA vs 200-day SMA	50over200
5Y total return	-45.14%
All Time High	39.5
All Time High Change	-84.86%
All Time High Date	2018-06-07
All Time Low	2.85
All Time Low Change	109.82%
All Time Low Date	2020-10-29
ATR	0.32
Beta	1.32
Beta1y	0.64
Beta2y	0.88
Ch YTD	-10.08
High	6.04
High52	10.2
High52 Date	2025-07-24
High52ch	-41.37%
Low	5.85
Low52	3.86
Low52 Date	2026-03-30
Low52ch	54.92%
Ma50ch	-8.1%
Price vs 200-day SMA	1.61%
RSI	41.84
RSI Monthly	42.26
RSI Weekly	49.36
Sharpe ratio	-0.39x
Sortino ratio	-0.49
Total Return	-2.53%
Tr YTD	-10.08
Tr1m	-11.28%
Tr1w	4.36%
Tr3m	12.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	4
Analyst Price Target Top	$15
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.05
Earnings Revenue Estimate	81,901,464x
Earnings Revenue Estimate Growth	18.04x
Operating Income	$-31.4M
Operating margin	-10.42
Price target	$14.67
Price Target Change	$145
Price Target Change Top	$151

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,042,829%
Float Percent	75.99%
Net Borrowing	34,981,000
Shares Insiders	11.08%
Shares Institutions	60.54%
Shares Out	65,854,751
Shares Qo Q	-0.25%
Shares Yo Y	2.53%
Short Float	12.03%
Short Ratio	7.66
Short Shares	9.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-60M
Average Volume	807,945.65x
Bv Per Share	-0.44
CAPEX	$-3.5M
Ch1m	-11.28
Ch1w	4.36
Ch1y	-37.58
Ch3m	12.62
Ch3y	-19.3
Ch5y	-45.14
Ch6m	21.55
Change	-0.17%
Change From Open	-0.33
Close	5.99
Days Gap	0.17
Depreciation Amortization	8,289,000
Dollar Volume	4,168,131.8
Earnings Date	2026-08-05
Earnings Time	amc
EBIT	$-24.3M
EBITDA	$-16M
EPS	$-0.67
F Score	2
FCF	$-40.1M
FCF EV Yield	-7.88x
FCF Per Share	$-0.61
Financing CF	26,587,000
Fiscal Year End	December
Founded	2,012
Goodwill	21,208,000
Income Tax	$861,000
Investing CF	-8,282,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-03
Ma150	5.59
Ma150ch	7.05%
Ma20	6.42
Ma20ch	-6.81%
Net CF	-18,102,000
Next Earnings Date	2026-08-05
Open	6
Optionable	Yes
Position In Range	68.42
Post Close	5.98
Postmarket Change Percent	-0.5
Postmarket Price	$5.95
Ppne	12,125,000
Price Date	2026-07-24
Relative Volume	0.86x
Revenue	301,791,000x
SBC By Revenue	6.59x
Share Based Comp	19,886,000
Tax By Revenue	0.29x
Tr6m	21.55%
Us State	California
Volume	697,012
Z Score	-1.83

Evolus, Inc. (EOLS)

Coverage state: Market snapshot only — no published research

Generate the first EOLS analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · EOLS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EOLS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on EOLS

Frequently asked questions